Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72377122 | 7237712 | 2 | F | 20080421 | 20131218 | 20091217 | 20131231 | EXP | 2009S1008832 | CB FLEET | 52.00 | YR | M | N | 160.00000 | LBS | 20131230 | LW | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72377122 | 7237712 | 1 | PS | FLEET PHOSPHO-SODA | 1 | D | D | 0 | |||||||||||
72377122 | 7237712 | 3 | C | LISINOPRIL HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE, LISINOPRIL) (TABLET) | 2 | 0 | |||||||||||||
72377122 | 7237712 | 5 | C | ASPIR-LOW (ACETYLSALICYLIC ACID) (81 MILLIGRAM, ENTERIC-COATED TABLET) | 2 | 0 | |||||||||||||
72377122 | 7237712 | 7 | C | OCUVITE (ASCORBIC ACID, TOCOPHEROL, RETINOL) (TABLET) | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
72377122 | 7237712 | 1 | Colonoscopy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
72377122 | 7237712 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
72377122 | 7237712 | Anaemia | |
72377122 | 7237712 | Hyperparathyroidism | |
72377122 | 7237712 | Renal failure chronic |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
72377122 | 7237712 | HP |
Therapies reported
no results found |